United States Oral Anticoagulants Market Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Oral Anticoagulants

Revenue, means the sales value of Oral Anticoagulants

This report studies sales (consumption) of Oral Anticoagulants in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Oral Anticoagulants in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Oral Anticoagulants Market Report 2016

Table of Contents
United States Oral Anticoagulants Market Report 2016
1 Oral Anticoagulants Overview
1.1 Product Overview and Scope of Oral Anticoagulants
1.2 Classification of Oral Anticoagulants
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Oral Anticoagulants
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Oral Anticoagulants (2011-2021)
1.4.1 United States Oral Anticoagulants Sales and Growth Rate (2011-2021)
1.4.2 United States Oral Anticoagulants Revenue and Growth Rate (2011-2021)
2 United States Oral Anticoagulants Competition by Manufacturers
2.1 United States Oral Anticoagulants Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Oral Anticoagulants Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Oral Anticoagulants Average Price by Manufactures (2015 and 2016)
2.4 Oral Anticoagulants Market Competitive Situation and Trends
2.4.1 Oral Anticoagulants Market Concentration Rate
2.4.2 Oral Anticoagulants Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Oral Anticoagulants Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Oral Anticoagulants Sales and Market Share by Type (2011-2016)
3.2 United States Oral Anticoagulants Revenue and Market Share by Type (2011-2016)
3.3 United States Oral Anticoagulants Price by Type (2011-2016)
3.4 United States Oral Anticoagulants Sales Growth Rate by Type (2011-2016)
4 United States Oral Anticoagulants Sales (Volume) by Application (2011-2016)
4.1 United States Oral Anticoagulants Sales and Market Share by Application (2011-2016)
4.2 United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Oral Anticoagulants Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Oral Anticoagulants Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Oral Anticoagulants Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Oral Anticoagulants Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Oral Anticoagulants Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Oral Anticoagulants Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Oral Anticoagulants Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Oral Anticoagulants Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Oral Anticoagulants Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Oral Anticoagulants Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Oral Anticoagulants Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Oral Anticoagulants Manufacturing Cost Analysis
6.1 Oral Anticoagulants Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Oral Anticoagulants
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Oral Anticoagulants Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Oral Anticoagulants Market Forecast (2016-2021)
10.1 United States Oral Anticoagulants Sales, Revenue Forecast (2016-2021)
10.2 United States Oral Anticoagulants Sales Forecast by Type (2016-2021)
10.3 United States Oral Anticoagulants Sales Forecast by Application (2016-2021)
10.4 Oral Anticoagulants Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Oral Anticoagulants
Table Classification of Oral Anticoagulants
Figure United States Sales Market Share of Oral Anticoagulants by Type in 2015
Table Application of Oral Anticoagulants
Figure United States Sales Market Share of Oral Anticoagulants by Application in 2015
Figure United States Oral Anticoagulants Sales and Growth Rate (2011-2021)
Figure United States Oral Anticoagulants Revenue and Growth Rate (2011-2021)
Table United States Oral Anticoagulants Sales of Key Manufacturers (2015 and 2016)
Table United States Oral Anticoagulants Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Oral Anticoagulants Sales Share by Manufacturers
Figure 2016 Oral Anticoagulants Sales Share by Manufacturers
Table United States Oral Anticoagulants Revenue by Manufacturers (2015 and 2016)
Table United States Oral Anticoagulants Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Oral Anticoagulants Revenue Share by Manufacturers
Table 2016 United States Oral Anticoagulants Revenue Share by Manufacturers
Table United States Market Oral Anticoagulants Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Oral Anticoagulants Average Price of Key Manufacturers in 2015
Figure Oral Anticoagulants Market Share of Top 3 Manufacturers
Figure Oral Anticoagulants Market Share of Top 5 Manufacturers
Table United States Oral Anticoagulants Sales by Type (2011-2016)
Table United States Oral Anticoagulants Sales Share by Type (2011-2016)
Figure United States Oral Anticoagulants Sales Market Share by Type in 2015
Table United States Oral Anticoagulants Revenue and Market Share by Type (2011-2016)
Table United States Oral Anticoagulants Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oral Anticoagulants by Type (2011-2016)
Table United States Oral Anticoagulants Price by Type (2011-2016)
Figure United States Oral Anticoagulants Sales Growth Rate by Type (2011-2016)
Table United States Oral Anticoagulants Sales by Application (2011-2016)
Table United States Oral Anticoagulants Sales Market Share by Application (2011-2016)
Figure United States Oral Anticoagulants Sales Market Share by Application in 2015
Table United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
Figure United States Oral Anticoagulants Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Oral Anticoagulants Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Oral Anticoagulants Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Oral Anticoagulants Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Oral Anticoagulants Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Oral Anticoagulants Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Oral Anticoagulants Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Oral Anticoagulants Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Oral Anticoagulants Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Oral Anticoagulants Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Oral Anticoagulants Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Anticoagulants
Figure Manufacturing Process Analysis of Oral Anticoagulants
Figure Oral Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Oral Anticoagulants Major Manufacturers in 2015
Table Major Buyers of Oral Anticoagulants
Table Distributors/Traders List
Figure United States Oral Anticoagulants Production and Growth Rate Forecast (2016-2021)
Figure United States Oral Anticoagulants Revenue and Growth Rate Forecast (2016-2021)
Table United States Oral Anticoagulants Production Forecast by Type (2016-2021)
Table United States Oral Anticoagulants Consumption Forecast by Application (2016-2021)
  • Global Niacinamide Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Niacinamide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Niacinamide in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Peripheral Arterial Disease (PAD) Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Peripheral Arterial Disease (PAD) Therapeutics in these regions, from 2012 to 2022 (forecast), covering ......
  • Global Bio Pharma Buffer Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Bio Pharma Buffer market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bio Pharma Buffer in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • Global Neurofibromatoses Type II Therapecutics Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 108
    In this report, the global Neurofibromatoses Type II Therapecutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neurofibromatoses Type II Therapecutics in these regions, from 2012 to 2022 (forecast), covering - North Ame......
  • Global Allergic Conjunctivitis Drug Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Allergic Conjunctivitis Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Allergic Conjunctivitis Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Thrombotic Thrombocytopenic Purpura Treatment Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Thrombotic Thrombocytopenic Purpura Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Thrombotic Thrombocytopenic Purpura Treatment in these regions, from 2012 to 2022 (forecast), covering ......
  • Global Chagas Disease Drug Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Chagas Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chagas Disease Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Beta Secretase 1 Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 119
    In this report, the global Beta Secretase 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Beta Secretase 1 in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Transforming Growth Factor Beta 1 Market Research Report 2017
    Published: 13-Dec-2017        Price: US 2900 Onwards        Pages: 112
    In this report, the global Transforming Growth Factor Beta 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Transforming Growth Factor Beta 1 in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs